Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Dec; 143(3):511-515.

View in: PubMed

subject areas

Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Endometrioid
Chemotherapy, Adjuvant
Cisplatin
Cytoreduction Surgical Procedures
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Staging
Neoplasm, Residual
Neoplasms, Cystic, Mucinous, and Serous
Ovarian Neoplasms
Paclitaxel
Prognosis
Reoperation
Survival Rate

authors with profiles

William Thomas Creasman